Compare StocksABBV vs LHX

AbbVie Inc. (ABBV) vs L3Harris Technologies, Inc. (LHX): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. LHX is undervalued at $295, with an intrinsic value of $423 and a margin of safety of 30%. Of the two, LHX has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
LHX
L3Harris Technologies, Inc.
$294.82

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
LHX
  • Free cash flow has grown at a 12.1% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $4.36 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
LHX
  • 9 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
LHX
Valuation
$20.81B
Free Cash Flow
N/A
5.44%
FCF Yield
N/A
105.60
Trailing P/E
31.98
13.32
Forward P/E
21.63
Quality & Moat
21.89%
ROIC
3.20%
N/A
ROE
7.01%
72.03%
Gross Margin
30.41%
0.61
PEG Ratio
1.78
Balance Sheet Safety
N/A
Net Debt / Equity
0.30
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
3.23
3.11%
Dividend Yield
0.92%
ABBV: 6Ties: 1LHX: 1
ABBVLHX

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

LHX

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
LHX
$9.04
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.68B
Δ Market Cap
+$15.16B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
LHX
30.3% Margin of Safety
Price is 30.3% below estimated fair value
Current Price: $294.82
Fair Value: $423.25
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

LHX

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
LHX
59/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
LHX
-2.38
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
LHX
Insiders 0.4%Institutions 89.4%Retail & Other 10.2%
No. of Institutional Holders2,134
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
LHX
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
LHX
1
Sells (3M)
9
Sells (12M)
Total value (12M): $65.34M
RAKITA MELANIE
Officer
$676,781
@ $310.45 · 2026-05-05
RAMBEAU JON
Officer
$2.05M
@ $370.32 · 2026-03-02
MEHTA SAMIR
Officer
$2.05M
@ $370.32 · 2026-03-02
RAKITA MELANIE
Officer
$1.09M
@ $348.38 · 2026-03-02
MEHTA SAMIR
Officer
$1.64M
@ $338.85 · 2026-02-05
KUBASIK CHRISTOPHER E
Chief Executive Officer
$4.27M
@ $301.05 · 2025-11-13
KUBASIK CHRISTOPHER E
Chief Executive Officer
$23.23M
@ $279.90 · 2025-09-12
KUBASIK CHRISTOPHER E
Chief Executive Officer
$10.82M
@ $269.52 · 2025-08-11
KUBASIK CHRISTOPHER E
Chief Executive Officer
$19.52M
@ $271.14 · 2025-07-29
KUBASIK CHRISTOPHER E
Chief Executive Officer
$8.76M
@ $248.39 · 2025-06-12
ZOISS EDWARD J
President
$490,000
@ $245.00 · 2025-05-27
RAMBEAU JON
Officer
$718,228
@ $226.00 · 2025-03-10
ZOISS EDWARD J
Officer
$1.09M
@ $211.68 · 2025-03-07
NIEBERGALL ROSS S.
Officer
$288,412
@ $210.06 · 2024-12-30
NIEBERGALL ROSS S.
Officer
$376,879
@ $213.65 · 2024-12-23
NIEBERGALL ROSS S.
Officer
$394,466
@ $223.62 · 2024-12-16
NIEBERGALL ROSS S.
Officer
$845,000
@ $260.00 · 2024-11-08
NIEBERGALL ROSS S.
Officer
$740,815
@ $247.93 · 2024-11-04
KUBASIK CHRISTOPHER E
Chief Executive Officer
$5.30M
@ $248.11 · 2024-10-31
NIEBERGALL ROSS S.
Officer
$731,104
@ $244.68 · 2024-10-02
NIEBERGALL ROSS S.
Officer
$707,200
@ $236.68 · 2024-09-03
MIKUEN SCOTT T
General Counsel
$6.15M
@ $233.01 · 2024-07-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
LHX
FearGreed
😐Neutral(44/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
LHX
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (44)
View ABBV Full AnalysisView LHX Full Analysis

Frequently Asked Questions: ABBV vs LHX

Is AbbVie Inc. or L3Harris Technologies, Inc. more undervalued in 2026?

Based on our discounted cash flow model, LHX trades at a 30.3% margin of safety (intrinsic value $423 vs. price $295), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or L3Harris Technologies, Inc.?

ABBV scores 82/100 (Wide moat), while LHX scores 59/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is L3Harris Technologies, Inc. in financial distress?

LHX's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or L3Harris Technologies, Inc.?

ABBV earns 21.9% ROIC versus LHX's 3.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or L3Harris Technologies, Inc.'s?

LHX's dividend earns a safety score of 84/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). LHX has raised its dividend for 3 consecutive years.